178 related articles for article (PubMed ID: 6141515)
1. Alpha-melanocyte stimulating hormone increases plasma levels of glucagon and insulin in rabbits.
Knudtzon J
Life Sci; 1984 Feb; 34(6):547-54. PubMed ID: 6141515
[TBL] [Abstract][Full Text] [Related]
2. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits--influences of selective blocking drugs.
Knudtzon J
Acta Physiol Scand; 1984 Mar; 120(3):353-61. PubMed ID: 6146241
[TBL] [Abstract][Full Text] [Related]
3. Acute in-vivo effects of adrenocorticotrophin on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits: involvement of the alpha-adrenergic nervous system.
Knudtzon J
J Endocrinol; 1984 Mar; 100(3):345-52. PubMed ID: 6321628
[TBL] [Abstract][Full Text] [Related]
4. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
Knudtzon J
Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the autonomic nervous system in the in vivo TRH-induced increases in the plasma levels of glucagon, insulin and glucose in rabbits.
Knudtzon J
Horm Metab Res; 1985 Feb; 17(2):53-7. PubMed ID: 3921449
[TBL] [Abstract][Full Text] [Related]
6. Thyrotropin-releasing hormone increases plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
Knudtzon J
Horm Metab Res; 1981 Jul; 13(7):371-5. PubMed ID: 6792023
[TBL] [Abstract][Full Text] [Related]
7. The modulatory role of alpha-melanocyte stimulating hormone administered spinally in the regulation of blood glucose level in d-glucose-fed and restraint stress mouse models.
Sim YB; Park SH; Kim SS; Lim SM; Jung JS; Suh HW
Neuropeptides; 2014 Aug; 48(4):207-12. PubMed ID: 24912936
[TBL] [Abstract][Full Text] [Related]
8. Hypoinsulinemic and hyperglycemic effects of beta-endorphin in rabbits.
Knudtzon J
Horm Metab Res; 1986 Aug; 18(8):505-9. PubMed ID: 2944808
[TBL] [Abstract][Full Text] [Related]
9. Dopamine during alpha- or beta-adrenergic blockade in man. Hormonal, metabolic, and cardiovascular effects.
Lorenzi M; Karam JH; Tsalikian E; Bohannon NV; Gerich JE; Forsham PH
J Clin Invest; 1979 Feb; 63(2):310-7. PubMed ID: 34629
[TBL] [Abstract][Full Text] [Related]
10. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
Rizza RA; Cryer PE; Gerich JE
J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
[TBL] [Abstract][Full Text] [Related]
11. Influence of blockade of alpha 1-adrenoceptors, beta 1-adrenoceptors and vasopressin V1A receptors on the cardiovascular effects of gamma 2-melanocyte-stimulating hormone (gamma 2-MSH).
Van Bergen P; De Winter TY; De Wildt DJ; Versteeg DH
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):720-6. PubMed ID: 9205956
[TBL] [Abstract][Full Text] [Related]
12. The integrated effect of adrenergic blockade on glucose, fatty acid, and glycerol kinetics: responses in the basal state and during hormonal control with somatostatin-hormonal infusion.
Shaw JH; Wolfe RR
J Surg Res; 1987 Mar; 42(3):257-72. PubMed ID: 2881026
[TBL] [Abstract][Full Text] [Related]
13. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
[TBL] [Abstract][Full Text] [Related]
14. Effects of pro-opiomelanocortin-derived peptides on plasma levels of glucagon, insulin and glucose.
Knudtzon J
Horm Metab Res; 1986 Sep; 18(9):579-83. PubMed ID: 3023222
[TBL] [Abstract][Full Text] [Related]
15. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
[TBL] [Abstract][Full Text] [Related]
16. Interaction of adrenergic agents with alpha-melanocyte-stimulating hormone and infrared irradiation of the iris in the rabbit eye.
Bengtsson E
Invest Ophthalmol Vis Sci; 1977 Mar; 16(3):209-17. PubMed ID: 191423
[TBL] [Abstract][Full Text] [Related]
17. Different acute in vivo effects of bacterial derived and pituitary growth hormone preparations on plasma levels of glucagon, insulin and free fatty acids in rabbits.
Knudtzon J; Edminson PD; Reichelt KL
Horm Res; 1985; 21(1):10-8. PubMed ID: 3882538
[TBL] [Abstract][Full Text] [Related]
18. Intracameral administration of alpha-MSH increases intraocular pressure in rabbits.
Hernandez DE; Simons KB; Spampinato D; Peiffer RL; Drago F
Neuropeptides; 1985 Dec; 6(6):553-9. PubMed ID: 4080114
[TBL] [Abstract][Full Text] [Related]
19. Acute in vivo stimulatory effects of human pituitary lipid-mobilizing factor on plasma levels of glucagon and insulin in rabbits.
Knudtzon J; Winsnes A; Oyasaeter S; Foss I; Trygstad O
Horm Metab Res; 1984 Dec; 16 Suppl 1():1-6. PubMed ID: 6398246
[TBL] [Abstract][Full Text] [Related]
20. Sympathetic nervous system mediation of acute cardiovascular actions of gamma 2-melanocyte-stimulating hormone.
Callahan MF; Kirby RF; Wolff DW; Strandhoy JW; Lymangrover JR; Johnson AK; Gruber KA
Hypertension; 1985; 7(3 Pt 2):I145-50. PubMed ID: 2860063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
